Vergoeding 2018-2022 voor ATC-subgroep N03AX : Overige anti-epileptica
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| N03AX09 Lamotrigine (Lamictal ®) | 2.692.800 | 2.755.500 | 3.045.300 | 3.412.900 | 3.343.400 |
| N03AX10 Felbamaat (Taloxa ®) | 118.920 | 118.360 | 122.180 | 104.640 | 106.080 |
| N03AX11 Topiramaat (Topamax ®) | 1.107.300 | 1.297.500 | 1.433.700 | 1.445.600 | 1.506.000 |
| N03AX12 Gabapentine (Neurontin ®) | 1.584.900 | 1.875.700 | 1.948.400 | 2.134.300 | 2.414.100 |
| N03AX14 Levetiracetam (Keppra ®) | 5.208.800 | 5.189.500 | 6.781.300 | 7.081.600 | 7.329.500 |
| N03AX15 Zonisamide (Zonegran ®) | 383.930 | 367.090 | 371.670 | 366.790 | 378.020 |
| N03AX16 Pregabaline (Lyrica ®) | 9.328.700 | 8.517.000 | 9.089.800 | 7.461.100 | 7.242.600 |
| N03AX17 Stiripentol (Diacomit ®) | 451.630 | 423.970 | 410.690 | 420.200 | 465.890 |
| N03AX18 Lacosamide (Vimpat ®) | 4.198.300 | 4.920.400 | 5.480.400 | 5.517.700 | 6.369.300 |
| N03AX22 Perampanel (Fycompa ®) | 593.370 | 676.250 | 754.020 | 817.140 | 929.720 |
| N03AX23 Brivaracetam (Briviact ®) | 950.000 | 1.655.100 | 2.217.300 | 2.884.200 | 3.819.100 |
| N03AX24 Cannabidiol (Epidyolex ®) | . | . | . | . | 20.547 |
| N03AX25 Cenobamaat (Ontozry ®) | . | . | . | . | 71.749 |
| Totaal | 26.618.650 | 27.796.370 | 31.654.760 | 31.646.170 | 33.996.006 |